US: DVTC - Development Technologies Corp

Yield per half year: +51.2%
Dividend yield: 0.00%
Sector: Financials

Share chart Development Technologies Corp


About Development Technologies Corp

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.


Industry Capital Markets
Sector Financials
Валюта usd
Сайт https://www.pegasusbiosciences.com
Цена ао 9.45
Change price per day: 0% (9.45)
Change price per week: 0% (9.45)
Change price per month: 0% (9.45)
Change price per 3 month: +5% (9)
Change price per half year: +51.2% (6.25)
Change price per year: +58.82% (5.95)
Change price per 3 year: -71.28% (32.9)
Change price per 5 year: +490.63% (1.6)
Change price per year to date: +51.2% (6.25)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 0 0
Yield EPS, % 0 0
Total: 0



Head Job title Payment Year of birth
Mr. Daniel P. Kesonen Chairman, CEO & President
Mr. Robert Zerbe Founder
Mr. Robert Dombey Founder

Address: United States, Palm Beach Gardens, 4440 PGA Boulevard - open in Google maps, open in Yandex maps
Website: https://www.pegasusbiosciences.com